Ovarian NeoplasmsCystadenomaBrenner TumorGranulosa Cell TumorSertoli-Leydig Cell TumorThecomaCystadenocarcinomaDysgerminomaSertoli Cell TumorIncidenceOvarian CystsDermoid CystOvarian DiseasesSex Cord-Gonadal Stromal TumorsCystadenoma, SerousTeratomaCarcinomaRisk FactorsRetrospective StudiesAdenocarcinomaNeoplasm StagingProspective StudiesNeoplasmsImmunohistochemistryInfant, NewbornPostoperative ComplicationsTreatment OutcomeFollow-Up StudiesAge DistributionCohort StudiesPancreatic NeoplasmsTime FactorsRegistriesPopulation SurveillanceSex DistributionAge FactorsNeoplasms, Cystic, Mucinous, and SerousDouble-Blind MethodUnited StatesSkin NeoplasmsSurvival RateLung NeoplasmsRodent DiseasesEnglandPregnancyRisk AssessmentNeoplasms, Multiple PrimaryPrevalencePrognosisRecurrenceSex FactorsMinnesotaNeoplasms, Second PrimaryKidney NeoplasmsRiskItalySurvival AnalysisAthletic InjuriesMultivariate AnalysisSeasonsBreast NeoplasmsVenous ThrombosisHospitalizationJapanDrug Administration ScheduleInfant, Newborn, DiseasesThyroid NeoplasmsAntiemeticsInjury Severity ScoreDenmarkSwedenLeukemiaAcute DiseaseVomitingGreat BritainSurgical Wound InfectionAdenocarcinoma, MucinousDrug-Related Side Effects and Adverse ReactionsLogistic ModelsChi-Square DistributionLiver NeoplasmsSeverity of Illness IndexKaplan-Meier EstimateOdds RatioMyeloproliferative DisordersNeoplasms, Radiation-InducedProportional Hazards ModelsNetherlandsDNA, NeoplasmSEER ProgramNeoplasms, ExperimentalBacteremiaDrug Therapy, CombinationMilitary PersonnelComorbidityParotid NeoplasmsAnesthesia, GeneralMass ScreeningIndiaCongenital Abnormalities